Recital 18, Directive (EU) 1998/44

In forcesince 6 Jul 1998

Whereas, since the patent system provides insufficient incentive for encouraging research into and production of biotechnological medicines which are needed to combat rare or ‘orphan’ diseases, the Community and the Member States have a duty to respond adequately to this problem;